The subject matter described herein is directed to pyruvate kinase activating compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for the treatment of diseases associated with PKR and/or PKM2, such as pyruvate kinase deficiency, sickle cell disease, and beta-thalassemia.
本文描述的主题是针对式I的
丙酮酸激酶激活化合物及其药用盐,制备这些化合物的方法,包含这些化合物的药物组合物以及用于治疗与PKR和/或PKM2相关疾病的化合物的给药方法,例如
丙酮酸激酶缺乏症、镰状细胞病和β地中海贫血。